2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z

Naïve and Interferon-gamma Activated Mesenchymal Stem Cells Differentially Affect Immune Responses In Vitro and In Vivo.

R. Patil,¹ K. Premanand,¹ L. Halliday,¹ E. Szilagyi,¹ M. Willman,² J. Yu,¹ R. Hickey,¹ D. Berman,² A. Antony,¹ F. Pan,¹ X. Wang,¹ K. McHenry,⁴ D. Salomon,³ N. Kenyon,² A. Bartholomew.¹
Nafamostat Mesilate Ameliorates Ischemia-Reperfusion Renal Injury via Anti-Apoptotic Mechanism.

D. Choi,¹ J. Jeong,² H. Bae,¹ Y. Ham,¹ K. Lee,¹ K. Na.¹
NAFLD in Kidney Transplant Candidates.

N. Kemmer, J. Buggs.
National Trends in Utilization of Donation After Cardiac Death Donor Livers for Transplantation.

S. Kubal,¹ R. Mangus,¹ B. Ekser,¹ R. Amos,² J. Fridell.¹
National Variation in Liver Transplant Immunosuppression in the U.S..

M. Nazzal,¹ R. Ouseph,¹ M. Schnitzler,¹ Z. Zhang,¹ D. Axelrod,² D. Segev,³ A. Naik,⁴ H. Randall,¹ D. Brennan,⁵ B. Kasiske,⁶ G. Hess,⁷ T. Alhamad,⁵ K. Lentine.¹
National Variation in US Kidney Transplant Induction Therapy.

V. Dharnidharka,¹ A. Naik,² T. Alhamad,¹ D. Axelrod,³ M. Schnitzler,^4,6 Z. Zhang,⁴ S. Bae,⁵ D. Brennan,¹ D. Segev,⁵ H. Randall,⁴ M. Nazzal,⁴ R. Ouseph,⁴ B. Kasiske,⁶ K. Lentine.⁴
Necroptotic Cellular Death Modulates TNFα Mediated Inflammation and Cardiac Allograft Rejection in Mice.

R. Ang, P. Heeger, A. Ting.
Neighborhood Poverty and Racial/Ethnic Disparities in Access to Live Donor Kidney Transplantation in the US.

T. Purnell, X. Luo, D. Crews, S. Bae, L. Kucirka, L. Cooper, D. Segev.
Nephrectomy of the Failed First Kidney Allograft Predisposes Kidney Transplant Recipients to Presensitization with Alloreactive T-Cells and Inferior Allograft Survival After Retransplantation.

T. Schachtner,^1,2 M. Stein,¹ P. Reinke.^1,2
Neurogenic Orthostatic Hypotension: An Iatrogenic Complication of Successful Pancreas Transplantation?

S. Kuten,¹ E. Simpson,¹ A. Gaber,¹ D. Nguyen,¹ E. Graviss,¹ S. Patel,² R. Knight.¹
Neuropeptide PACAP Prevents Hepatocyte Damage by Promoting Yes-Associated Protein (YAP) in Mouse Liver Ischemia/Reperfusion Injury.

Y. Liu,^1,2 C. Zhang,^1,3 R. Busuttil,¹ J. Kupiec-Weglinski,¹ Q. Xia,^1,2 H. Ji.¹
Neutering Worsens Liver Ischemia/Reperfusion Injury in Both Male and Female Mice.

D. Murken,¹ D. Aufhauser Jr,¹ S. Concors,¹ Z. Wang,¹ G. Ge,¹ W. Hancock,² M. Levine.¹
Neutropenia in Kidney and Liver Transplant Recipients: Risk Factors and Consequences.

T. Mavrakanas,¹ M. Fournier,² S. Clairou,² J. Amiel,² D. Vinh,³ C. Coursol,² D. Thirion,² M. Cantarovich.⁴
Neutropenia in Kidney Transplantation: A Hidden Threat to Graft Survival.

A. Vergottini, A. Karabala, P. Abrams, J. Verbesey, S. Ghasemian, J. Moore, M. Grafals, B. Javaid, M. Cooper, A. Gilbert.
New Approach for Targeted Immunotherapy in Vascularized Composite Allotransplantation.

F. Feturi,¹ H. Wang,² Y. Brudno,² V. Erbas,³ Z. Zhang,³ H. Sahin,³ D. Mooney,² V. Gorantla,³ R. Venkataramanan.¹
Next-Generation Sequencing-Based Exosome MicroRNA Profiling for Specific Identification of Islet Damage.

P. Saravanan,¹ J. Gu,¹ X. Wang,¹ P. Nguyen,¹ G. Yoshimatsu,¹ M. Lawrence,¹ B. Naziruddin.²
NFAT-Regulated Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Recipients – A Randomized Controlled Trial.

A. Webber,¹ V. Tatapudi,² C. Leung,³ F. Vincenti.^1,3
NK Cells Respond to CMV Lysate by Inducing IFNγ and CD107a Surface Expression in an Antibody-Dependent Manner: This Represents a Cytokine Flow Cytometry (CFC) Assay That Could Assess Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) as a Marker of CMV Immunity in Transplant Recipients.

S. Ge, C. Maggie, B.-H. Shin, A. Karasyov, S. Jordan, M. Toyoda.
NKG2C+ NK Cell Adaptive Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.

D. Redondo,¹ M. Crespo,¹ J. Yélamos,² A. Muntasell,² M. Pérez-Sáez,¹ C. Vilchez,³ J. Pascual,¹ M. Lóez-Botet.²
No Gains in Long-Term Survival Following Liver Transplantation Over the Past Three Decades.

A. Rana,¹ M. Kueht,¹ J. Moffett,¹ N. Galvan,¹ R. Cotton,¹ J. Vierling,^1,2 A. Mindikoglu,^1,2 C. O'Mahony,¹ J. Goss.¹
No Impact of One Year of Everolimus, as Compared to MPA, in the Reversal of Left Ventricular Hypertrophy in Elderly Renal Transplant Recipients – Preliminary Data from Then Everold Study.

E. David-Neto,¹ F. Agena,¹ M. Furtado,² A. Rodriges,² J. Andrade,² F. Lemos,¹ F. Paula.¹
Non-Directed Donors (NDD) Less Than 25 Years.

D. Larson, J. Wiseman, A. Roman, D. Berglund, H. Ibrahim, A. Matas.
Non-Directed Kidney Donor Candidate Referral, Care, and Attrition in an Online Portal.

R. Hays,¹ K. Schappe,¹ D. Kaufman,¹ D. Mandelbrot.²
Non-Donor-Specific Anti-HLA Antibodies Have an Adverse Impact in Kidney Graft Outcomes.

J. Malheiro,¹ S. Tafulo,² L. Dias,¹ L. Martins,¹ I. Beirão,¹ A. Castro-Henriques.¹
Non-Human Primate Auto-Immune Responses to Col V, Kα-1Tubulin and Vimentin Are P2X7R Dependent.

J. Sullivan,¹ E. Jankowska-Gan,¹ D. Kaufman,¹ L. Denlinger,² W. Burlingham.¹
Non-Invasive Detection of Rejection with ImmunoPET Imaging.

D. Mathews,¹ K. Lindsay,² P. Santangelo,² Y. Dong,¹ J. Tso,³ A. Adams.¹
Non-Medical Factors Contributing to Racial Disparity in Kidney Transplant Wait-Listing.

Y.-H. Ng,¹ S. Pankratz,¹ K. Bornemann,² E. Croswell,² J. Pleis,² R. Shapiro,³ M. Unruh,¹ L. Myaskovsky.²
Non-Renal Factors Predicting Combined Liver-Kidney Transplantation for Non-Dialysis-Requiring Wait-Listed End Stage Liver Disease Patients: 14 Years of US Experience.

A. Santos, M. Casey, K. Alquadan, J. Gregg, K. Womer.
Noninvasive Prognostication of Renal Allograft Failure Following BK Virus Associated Nephropathy – A Validation Study.

E. Abuhelaiqa, C. Snopkowski, C. Li, J. Lee, T. Muthukumar, H. Yang, M. Suthanthiran, D. Dadhania.
Noninvasive Renal Transplant Graft Monitoring in Single Institution Using Cell-Free DNA in Recipient Plasma via Insertion-Deletion Allele Polymorphism.

Y. Goh,¹ S. Ho,² L. Raman,¹ V. Anantharaman,³ T. Goh,³ S. Koay,² H. Tiong.¹
Nonmelanoma Skin Cancer Rates Are Not Affected by Chronic HIV(+) or HCV(+) Infection in Organ Transplant Recipients.

K. Nadhan, E. Usedom, S. Shipman, A. Doyle, G. Malat, E. Buchanan, C. Chung.
Normothermic Ex-Vivo Kidney Perfusion Improves Function of Extreme Marginal Renal Grafts Subjected to Prolonged Ischemia.

P. Urbanellis,¹ M. Hamar,¹ I. Linares,¹ D. Kollmann,¹ C. Cassol,² R. John,² P. Yip,¹ I. Mucsi,¹ A. Ghanekar,¹ D. Bagli,³ D. Grant,¹ L. Robinson,⁴ M. Selzner.¹
Normothermic Donor Lung Preservation with Portable EVLP Significantly Reduces Ischemia/Reperfusion Injury in Lung Recipients by Promoting Cytokine Antagonists.

C. Falk,¹ B. Wiegmann,² C. Neudörfl,¹ C. Kühn,² I. Tudorache,² M. Wvsar,² A. Haverich,² G. Warnecke.²
Normothermic Regional Perfusion of Donors Following Circulatory Death Improves Outcomes in Liver Transplantation.

E. Mowlem,¹ L. Randle,² C. Fear,¹ K. Crick,¹ S. Messer,⁴ S. Large,⁴ A. Butler,³ C. Watson.³
Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection.

C. Jadlowiec, P. Morgan, A. Nehra, M. Hathcock, W. Kremers, R. Wiesner, T. Taner.
Novel Application of Localized Nanodelivery of Anti-IL6 Protects Organ Transplant from Ischemia Reperfusion Injuries.

M. Uehara,¹ Z. Solhjou,¹ B. Bahmani,¹ O. Maarouf,¹ T. Ichimura,² C. Brooks,² W. Xu,¹ V. Kasinath,¹ N. Banouni,¹ A. Elkhal,³ I. Guleria,² M. McGrath,¹ S. Tullius,³ R. Abdi.¹
Novel Biomarkers for Segregating Lung Transplant Rejection Phenotypes.

J. Yang,¹ B. Vanaudenaerde,² T. Sigdel,¹ J. Liberto,¹ S. Verlden,² M. Sarwal.¹
Novel Cell Intrinsic Role of the Adaptor Protein TSAd in Maintaining Alloimmune T Regulatory Cell Function.

J. Wedel,^1,2 M. Stack,^1,2 T. Seto,^1,2 M. Sheehan,^1,2 K. Liu,^1,2 E. Flynn,^1,2 D. Briscoe.^1,2
Novel Classification of Membranoproliferative Glomerulonephritis Pattern of Injury in Renal Allograft Based on Immunofluorescence Microscopy: Precise Diagnosis and Prognosis Analysis.

J. Wen, X. Li, M. Zhang, F. Xu, X. Ni, J. Chen, Z. Tang, Z. Liu.
Novel Insights into the Synergism of CD40 Autoantibodies and suPAR in Kidney Transplant Patients with FSGS Recurrence.

T. Sigdel, C. Wei, F. Vencenti, J. Reiser, M. Sarwal.
Novel Personalized Immune-Monitoring Assay for Predicting Operational Tolerance by Using Humanized Mouse Model.

Y. Fukasaku,¹ R. Goto,¹ Y. Ganchiku,¹ M. Zaitsu,¹ M. Watanabe,¹ N. Kawamura,¹ Y. Koshizuka,¹ K. Yamashita,² T. Shimamura,³ A. Taketomi.¹
Novel Therapies for Diabetic Kidney Disease.

M. Nguyen, K. Kodama, M. Sarwal.
Nox4 and Oxidative Stress Mediate TGF-β1 Induced Human Kidney Proximal Cell Apoptosis in Ischemic Reperfusion Injury.

S.-H. Yoon,¹ S. Cho,¹ D.-I. Kim,¹ S.-R. Yoon,¹ W.-M. Hwang,¹ S.-L. Yu,² J. Kang.²
Nuclear Co-Repressor Complex Inhibition Reverses Benefit of HDAC2 Deletion in Renal Ischemia.

D. Aufhauser Jr,¹ D. Murken,¹ Z. Wang,¹ A. Samanta,² G. Ge,¹ T. Bhatti,³ P. Cole,⁴ J. Kalin,⁴ W. Hancock,^2,3 M. Levine.^1,5
Nucleic Acid Scavenging Microfiber Mesh Inhibits Trauma Induced Inflammation and Thrombosis After Organ Transplantation.

J. Kwun,¹ J. Lee,¹ J. Jackman,² M. Manook,¹ E. Elster,³ A. Kirk,¹ B. Sullenger.¹

Jump to: View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z